119 related articles for article (PubMed ID: 27770021)
41. Cardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1-Deficient Hyperlipidemic Mice.
Tang SY; Monslow J; R Grant G; Todd L; Pawelzik SC; Chen L; Lawson J; Puré E; FitzGerald GA
Circulation; 2016 Jul; 134(4):328-38. PubMed ID: 27440004
[TBL] [Abstract][Full Text] [Related]
42. Stimulation of prostanoid IP and EP(2) receptors dilates retinal arterioles and increases retinal and choroidal blood flow in rats.
Mori A; Saito M; Sakamoto K; Narita M; Nakahara T; Ishii K
Eur J Pharmacol; 2007 Sep; 570(1-3):135-41. PubMed ID: 17628525
[TBL] [Abstract][Full Text] [Related]
43. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
Bhattacherjee P; Williams BS; Paterson CA
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3047-53. PubMed ID: 10549672
[TBL] [Abstract][Full Text] [Related]
44. Prostanoid receptor signaling relevant to tumor growth and angiogenesis.
Majima M; Amano H; Hayashi I
Trends Pharmacol Sci; 2003 Oct; 24(10):524-9. PubMed ID: 14559404
[No Abstract] [Full Text] [Related]
45. E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2.
Okano M; Sugata Y; Fujiwara T; Matsumoto R; Nishibori M; Shimizu K; Maeda M; Kimura Y; Kariya S; Hattori H; Yokoyama M; Kino K; Nishizaki K
Immunology; 2006 Jul; 118(3):343-52. PubMed ID: 16827895
[TBL] [Abstract][Full Text] [Related]
46. Characterization of receptor subtypes involved in prostanoid-induced conjunctival pruritus and their role in mediating allergic conjunctival itching.
Woodward DF; Nieves AL; Friedlaender MH
J Pharmacol Exp Ther; 1996 Oct; 279(1):137-42. PubMed ID: 8858986
[TBL] [Abstract][Full Text] [Related]
47. Regulation of nerve growth factor by anti-inflammatory drugs, a steroid, and a selective cyclooxygenase 2 inhibitor in human intervertebral disc cells stimulated with interleukin-1.
Alimasi W; Sawaji Y; Endo K; Yorifuji M; Suzuki H; Kosaka T; Shishido T; Yamamoto K
Spine (Phila Pa 1976); 2013 Aug; 38(17):1466-72. PubMed ID: 23574818
[TBL] [Abstract][Full Text] [Related]
48. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
Iwanaga K; Okada M; Murata T; Hori M; Ozaki H
J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
[TBL] [Abstract][Full Text] [Related]
49. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
[TBL] [Abstract][Full Text] [Related]
50. Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat.
Blume C; Heise G; Mühlfeld A; Bach D; Schrör K; Gerhardz CD; Grabensee B; Heering P
Kidney Int; 1999 Nov; 56(5):1770-8. PubMed ID: 10571785
[TBL] [Abstract][Full Text] [Related]
51. Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors.
Kawahara K; Hohjoh H; Inazumi T; Tsuchiya S; Sugimoto Y
Biochim Biophys Acta; 2015 Apr; 1851(4):414-21. PubMed ID: 25038274
[TBL] [Abstract][Full Text] [Related]
52. Prostanoid receptors involved in the relaxation of human pulmonary vessels.
Walch L; Labat C; Gascard JP; de Montpreville V; Brink C; Norel X
Br J Pharmacol; 1999 Feb; 126(4):859-66. PubMed ID: 10193765
[TBL] [Abstract][Full Text] [Related]
53. Expression of prostanoid receptors (EP1, 2, 3, and 4) in normal and methimazole-treated mouse olfactory epithelium.
Fukuiri T; Takumida M; Nakashimo Y; Hirakawa K
Acta Otolaryngol; 2013 Jan; 133(1):70-6. PubMed ID: 22991925
[TBL] [Abstract][Full Text] [Related]
54. Involvement of prostaglandin E receptor EP3 subtype and prostacyclin IP receptor in decreased acid response in damaged stomach.
Nishio H; Terashima S; Nakashima M; Aihara E; Takeuchi K
J Physiol Pharmacol; 2007 Sep; 58(3):407-21. PubMed ID: 17928639
[TBL] [Abstract][Full Text] [Related]
55. Possible cross-regulation of the E prostanoid receptors.
Tober KL; Thomas-Ahner JM; Maruyama T; Oberyszyn TM
Mol Carcinog; 2007 Aug; 46(8):711-5. PubMed ID: 17538953
[TBL] [Abstract][Full Text] [Related]
56. Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle.
Krauss AH; Wiederholt M; Sturm A; Woodward DF
Exp Eye Res; 1997 Mar; 64(3):447-53. PubMed ID: 9196397
[TBL] [Abstract][Full Text] [Related]
57. Prostaglandins enhance epidermal growth factor-induced DNA synthesis in hepatocytes by stimulation of E prostanoid 3 and F prostanoid receptors.
Meisdalen K; Dajani OF; Christoffersen T; Sandnes D
J Pharmacol Exp Ther; 2007 Sep; 322(3):1044-50. PubMed ID: 17567965
[TBL] [Abstract][Full Text] [Related]
58. Brain prostanoid TP receptor-mediated adrenal noradrenaline secretion and EP3 receptor-mediated sympathetic noradrenaline release in rats.
Yokotani K; Okada S; Nakamura K; Yamaguchi-Shima N; Shimizu T; Arai J; Wakiguchi H; Yokotani K
Eur J Pharmacol; 2005 Apr; 512(1):29-35. PubMed ID: 15814087
[TBL] [Abstract][Full Text] [Related]
59. Prostanoid receptor antagonists: development strategies and therapeutic applications.
Jones RL; Giembycz MA; Woodward DF
Br J Pharmacol; 2009 Sep; 158(1):104-45. PubMed ID: 19624532
[TBL] [Abstract][Full Text] [Related]
60. The affinity, intrinsic activity and selectivity of a structurally novel EP
Coleman RA; Woodrooffe AJ; Clark KL; Toris CB; Fan S; Wang JW; Woodward DF
Br J Pharmacol; 2019 Mar; 176(5):687-698. PubMed ID: 30341781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
